Senseonics (NYSE:SENS) Raised to "Sell" at StockNews.com

Senseonics (NYSE:SENS - Get Free Report) was upgraded by analysts at StockNews.com to a "sell" rating in a report released on Monday.

A number of other analysts also recently commented on the company. Mizuho assumed coverage on Senseonics in a report on Thursday, April 10th. They set an "outperform" rating and a $2.00 price objective for the company. HC Wainwright reaffirmed a "buy" rating and set a $2.00 price target on shares of Senseonics in a research report on Wednesday, March 5th.

Senseonics Trading Down 4.0%

NYSE:SENS traded down $0.03 during trading hours on Monday, reaching $0.60. 5,932,245 shares of the stock were exchanged, compared to its average volume of 6,398,626. The company has a market capitalization of $392.53 million, a price-to-earnings ratio of -4.62 and a beta of 1.05. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17. Senseonics has a twelve month low of $0.25 and a twelve month high of $1.40. The business has a 50-day moving average of $0.65 and a two-hundred day moving average of $0.63.

Senseonics (NYSE:SENS - Get Free Report) last issued its quarterly earnings data on Monday, March 3rd. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.09). Senseonics had a negative return on equity of 842.25% and a negative net margin of 362.30%. During the same period in the previous year, the business posted ($0.07) EPS. On average, equities analysts predict that Senseonics will post -0.14 EPS for the current year.

Institutional Investors Weigh In On Senseonics

Several institutional investors and hedge funds have recently modified their holdings of the business. First Light Asset Management LLC bought a new position in shares of Senseonics during the 4th quarter worth about $3,366,000. Jane Street Group LLC boosted its position in Senseonics by 6,694.1% in the fourth quarter. Jane Street Group LLC now owns 6,118,786 shares of the company's stock valued at $3,203,000 after buying an additional 6,028,726 shares in the last quarter. Renaissance Technologies LLC acquired a new position in Senseonics in the fourth quarter valued at about $720,000. Millennium Management LLC lifted its position in shares of Senseonics by 299.0% during the fourth quarter. Millennium Management LLC now owns 1,088,029 shares of the company's stock worth $569,000 after purchasing an additional 815,332 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Senseonics by 9.7% during the fourth quarter. Geode Capital Management LLC now owns 6,405,100 shares of the company's stock worth $3,354,000 after purchasing an additional 566,704 shares in the last quarter. Institutional investors and hedge funds own 12.36% of the company's stock.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.